BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37987361)

  • 1. Discovery of Novel miRNAs in Colorectal Cancer: Potential Biological Roles and Clinical Utility.
    Minutentag IW; Seneda AL; Barros-Filhos MC; de Carvalho M; Souza VGP; Hasimoto CN; Moraes MPT; Marchi FA; Lam WL; Reis PP; Drigo SA
    Noncoding RNA; 2023 Oct; 9(6):. PubMed ID: 37987361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer.
    Silva CMS; Barros-Filho MC; Wong DVT; Mello JBH; Nobre LMS; Wanderley CWS; Lucetti LT; Muniz HA; Paiva IKD; Kuasne H; Ferreira DPP; Cunha MPSS; Hirth CG; Silva PGB; Sant'Ana RO; Souza MHLP; Quetz JS; Rogatto SR; Lima-Junior RCP
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33804927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of stage-associated exosome miRNAs in colorectal cancer by improved robust and corroborative approach embedded miRNA-target network.
    Long F; Tian L; Chai Z; Li J; Tang Y; Liu M
    Front Med (Lausanne); 2022; 9():881788. PubMed ID: 36237545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
    Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
    Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer.
    Lin M; Duan B; Hu J; Yu H; Sheng H; Gao H; Huang J
    Oncol Lett; 2017 Jul; 14(1):1061-1067. PubMed ID: 28693274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer.
    Ding B; Yao M; Fan W; Lou W
    Aging (Albany NY); 2020 Mar; 12(6):5259-5279. PubMed ID: 32221048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
    Yong FL; Law CW; Wang CW
    BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.
    Eneh S; Heikkinen S; Hartikainen JM; Kuopio T; Mecklin JP; Kosma VM; Mannermaa A
    Anticancer Res; 2020 Jul; 40(7):3713-3722. PubMed ID: 32620610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.
    Rapado-González Ó; Majem B; Álvarez-Castro A; Díaz-Peña R; Abalo A; Suárez-Cabrera L; Gil-Moreno A; Santamaría A; López-López R; Muinelo-Romay L; Suarez-Cunqueiro MM
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31757017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs-Based Molecular Signature for
    Milanesi E; Dobre M; Bucuroiu AI; Herlea V; Manuc TE; Salvi A; De Petro G; Manuc M; Becheanu G
    J Immunol Res; 2020; 2020():4927120. PubMed ID: 32676506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
    Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
    J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs.
    Moreno EC; Pascual A; Prieto-Cuadra D; Laza VF; Molina-Cerrillo J; Ramos-Muñoz ME; Rodríguez-Serrano EM; Soto JL; Carrato A; García-Bermejo ML; Guillén-Ponce C
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30862091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas.
    Ardila HJ; Sanabria-Salas MC; Meneses X; Rios R; Huertas-Salgado A; Serrano ML
    Mol Clin Oncol; 2019 Aug; 11(2):201-207. PubMed ID: 31316774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
    Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
    Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer.
    Schee K; Lorenz S; Worren MM; Günther CC; Holden M; Hovig E; Fodstad O; Meza-Zepeda LA; Flatmark K
    PLoS One; 2013; 8(6):e66165. PubMed ID: 23824282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.